Data / Drug companies / Legacy Pharmaceutical Packaging, LLC
Legacy Pharmaceutical Packaging, LLC: 38 products in the FDA NDC directory, labeler code 68645
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Legacy Pharmaceutical Packaging, LLC (labeler code 68645) lists 38 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 38 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 10, 2022.
The request: Watch Legacy Pharmaceutical Packaging, LLC (FDA labeler code 68645): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68645
- Products in commercial distribution
- 38
- Packages
- 38
- Finished drugs by generic name
- 17
- Prescription products
- 38
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 7
- Earliest marketing start
- January 12, 1973
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 38 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 38 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lisinopril | 6 | 40 |
| Sertraline hydrochloride | 3 | 55 |
| Enalapril maleate | 3 | 32 |
| Amlodipine besylate | 3 | 49 |
| Metformin hydrochloride | 3 | 79 |
| Lisinopril and hydrochlorothiazide | 3 | 21 |
| Metoprolol tartrate | 2 | 46 |
| Escitalopram | 2 | 34 |
| Lovastatin | 2 | 22 |
| Fluoxetine | 2 | 42 |
| Ibuprofen | 2 | 190 |
| Glipizide | 2 | 39 |
| Famotidine | 1 | 138 |
| Metformin er 500 mg | 1 | 11 |
| Clopidogrel bisulfate | 1 | 31 |
| Hydrochlorothiazide | 1 | 51 |
| Finasteride | 1 | 31 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 26 | 68.4% |
| Tablet, film coated | 9 | 23.7% |
| Capsule | 2 | 5.3% |
| Tablet, extended release | 1 | 2.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Metformin | 68645-595 | Tablet, extended release | Generic drugs (ANDA) | March 10, 2022 |
| Famotidine | 68645-594 | Tablet, film coated | Generic drugs (ANDA) | September 22, 2021 |
| Lisinopril | 68645-613 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Lisinopril | 68645-612 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Lisinopril | 68645-611 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Lisinopril | 68645-610 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Lisinopril | 68645-609 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Lisinopril | 68645-608 | Tablet | Generic drugs (ANDA) | August 17, 2021 |
| Enalapril maleate | 68645-607 | Tablet | Generic drugs (ANDA) | October 1, 2020 |
| Enalapril maleate | 68645-606 | Tablet | Generic drugs (ANDA) | October 1, 2020 |
| Enalapril maleate | 68645-605 | Tablet | Generic drugs (ANDA) | April 28, 2020 |
| Metformin hydrochloride | 68645-584 | Tablet | Generic drugs (ANDA) | June 7, 2019 |
| Metformin hydrochloride | 68645-583 | Tablet | Generic drugs (ANDA) | June 7, 2019 |
| Metformin hydrochloride | 68645-582 | Tablet | Generic drugs (ANDA) | June 7, 2019 |
| Sertraline Hydrochloride | 68645-523 | Tablet | Generic drugs (ANDA) | July 21, 2016 |
| Sertraline Hydrochloride | 68645-522 | Tablet | Generic drugs (ANDA) | July 21, 2016 |
| Sertraline Hydrochloride | 68645-521 | Tablet | Generic drugs (ANDA) | July 21, 2016 |
| Amlodipine Besylate | 68645-516 | Tablet | Generic drugs (ANDA) | July 1, 2016 |
| Amlodipine Besylate | 68645-515 | Tablet | Generic drugs (ANDA) | July 1, 2016 |
| Escitalopram Oxalate | 68645-520 | Tablet, film coated | Generic drugs (ANDA) | June 16, 2016 |
| Escitalopram Oxalate | 68645-519 | Tablet, film coated | Generic drugs (ANDA) | June 16, 2016 |
| Ibuprofen | 68645-563 | Tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Ibuprofen | 68645-562 | Tablet, film coated | Generic drugs (ANDA) | December 21, 2015 |
| Finasteride | 68645-541 | Tablet, film coated | Generic drugs (ANDA) | June 13, 2015 |
| Clopidogrel | 68645-590 | Tablet, film coated | Generic drugs (ANDA) | May 17, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.